BIAF bioAffinity Technologies
- 1.870
- -0.120-6.03%
- 1.880
- +0.010+0.53%
bioAffinity Technologies News
BioAffinity Technologies News Update
bioAffinity Technologies, Inc. (NASDAQ:BIAF, BIAFW)) shares recent Company news. CyPath Lung Sales Ramp Up Month over Month Sales of CyPath Lung, our noninvasive diagnostic test for the early detection
BioAffinity Technologies Expands Campaign to Support American Cancer Society Initiative for Lung Cancer Screening
BioAffinity Technologies Files to Sell 1.63M Shares for Holders
BioAffinity Technologies Q4 EPS $(0.26) Up From $(0.44) YoY, Sales $2.21M Down From $2.35M YoY
bioAffinity Technologies (NASDAQ:BIAF) reported quarterly losses of $(0.26) per share. This is a 40.91 percent increase over losses of $(0.44) per share from the same period last year. The company re
Press Release: BioAffinity Technologies Reports Fourth Quarter and Full Year 2023 Financial Results
bioAffinity Technologies Reports Fourth Quarter and Full Year 2023 Financial Results SAN ANTONIO--(BUSINESS WIRE)--April 01, 2024-- bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnol
BioAffinity Technologies 4Q Rev $2.2M >BIAF
BioAffinity Technologies 4Q Rev $2.2M >BIAF
BioAffinity (BIAF) Gains Traction In Pre-Market Trading: What's Driving The Momentum?
Recent trading session has witnessed a notable increase in the price of BioAffinity Technologies, Inc. (NASDAQ: BIAF), which has carried over into pre-market activity. Pre-hour trading saw the stock rise 6.40% to $2.16 after closing at $2.03 in the previous session with a significant 32.68% gain. In spite of the lack of instant news, the ...
12 Health Care Stocks Moving In Monday's Intraday Session
GainersRegencell Bioscience (NASDAQ:RGC) shares rose 130.9% to $10.39 during Monday's regular session. The company's market cap stands at $135.2 million. TC BioPharm (Holdings) (NASDAQ:TCBP) shares in
BioAffinity Technologies Announces Closing of $2.5 Million Registered Direct Offering and Concurrent Private Placement
bioAffinity Technologies, Inc. (NASDAQ:BIAF) today announced it has closed a securities purchase agreement with institutional investors for the purchase and sale of 1,600,000 shares of common stock in a registered
Nasdaq Gains 100 Points; Campbell Soup Earnings Top Views
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 100 points on Wednesday. The Dow traded up 0.20% to 38,662.69 while the NASDAQ rose 0.64% to 16,041.08. Th
OCEA, RVSN and HOVR Among Mid-day Movers
12 Health Care Stocks Moving In Wednesday's Intraday Session
GainersAptorum Gr (NASDAQ:APM) stock moved upwards by 780.6% to $12.77 during Wednesday's regular session. The company's market cap stands at $66.1 million. NKGen Biotech (NASDAQ:NKGN) stock rose 302.
WallachBeth Capital Announces Pricing of BioAffinity Technologies $2.5 Million Registered Direct...
BeyondSpring, EnVVeno Medical, Aptorum Group Among Healthcare Movers
BioAffinity Technologies Shares Resume Trade
BioAffinity Technologies Shares Resume Trade
BioAffinity Technologies Shares Halted On Circuit Breaker To The Downside, Stock Now Down -25.7%
BioAffinity Technologies Shares Halted On Circuit Breaker To The Downside, Stock Now Down -25.7%
BioAffinity Technologies Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Private Placement
bioAffinity Technologies, Inc. (NASDAQ:BIAF) today announced it has entered into a securities purchase agreement with institutional investors for the purchase and sale of 1,600,000 shares of common stock in a registered
BioAffinity Technologies Shares Rise 11% On Surging Sales
By Ben Glickman Shares of BioAffinity Technologies rose Tuesday after the company flagged accelerating sales growth in its test to detect early-stage lung cancer. The stock was up 11% to $2.62 in mi
Regenxbio, Quoin Pharmaceuticals, Renalytix Among Healthcare Movers
BioAffinity Reports Surge in Early-stage Lung Cancer Test Orders
bioAffinity Technologies, Inc. (NASDAQ:BIAF; BIAFW), a company specializing in noninvasive early-stage cancer and lung disease tests, has reported a significant increase in orders and processing of its CyPath® Lung tests.
Analysis
Price Target
No Data
